Department of Intensive Care, Hopital Erasme, Brussels, Belgium.
Department of Infectious Diseases, Hopital Erasme, Brussels, Belgium.
Expert Opin Drug Metab Toxicol. 2021 May;17(5):543-554. doi: 10.1080/17425255.2021.1902985. Epub 2021 Mar 28.
: Mortality due to severe infections in critically ill patients undergoing continuous renal replacement therapy (CRRT) remains high. Nevertheless, rapid administration of adequate antibiotic therapy can improve survival. Delivering optimized antibiotic therapy can be a challenge, as standard drug regimens often result in insufficient or excessive serum concentrations due to significant changes in the volume of distribution and/or drug clearance in these patients. Insufficient drug concentrations can be responsible for therapeutic failure and death, while excessive concentrations can cause toxic adverse events.: We performed a narrative review of the impact of CRRT on the pharmacokinetics of the most frequently used antibiotics in critically ill patients. We have provided explanations for the changes in the PKs of antibiotics observed and suggestions to optimize dosage regimens in these patients.: Despite considerable efforts to identify optimal antibiotic dosage regimens for critically ill patients receiving CRRT, adequate target achievement remains too low for hydrophilic antibiotics in many patients. Whenever possible, individualized therapy based on results from therapeutic drug monitoring must be given to avoid undertreatment or toxicity.
: 在接受连续肾脏替代治疗 (CRRT) 的重症感染患者中,严重感染导致的死亡率仍然很高。然而,快速给予足够的抗生素治疗可以提高生存率。由于这些患者的分布容积和/或药物清除率发生显著变化,标准药物方案往往导致血清浓度不足或过高,因此提供优化的抗生素治疗可能具有挑战性。药物浓度不足可能导致治疗失败和死亡,而浓度过高则会引起毒性不良反应。: 我们对 CRRT 对重症患者最常用抗生素药代动力学的影响进行了叙述性综述。我们对观察到的抗生素药代动力学变化进行了解释,并为这些患者的剂量方案优化提供了建议。: 尽管为确定接受 CRRT 的重症患者的最佳抗生素剂量方案做出了相当大的努力,但在许多患者中,亲水性抗生素的靶目标达标率仍然太低。在可能的情况下,必须根据治疗药物监测的结果进行个体化治疗,以避免治疗不足或毒性。